{"gene":"OLIG1","run_date":"2026-06-10T05:19:52","timeline":{"discoveries":[{"year":2002,"finding":"OLIG1 and OLIG2 are required for both motoneuron and oligodendrocyte specification in the spinal cord pMN domain; Olig1/2 double-mutant mice lose motoneurons and fail to generate oligodendrocytes, with pMN progenitors instead generating V2 interneurons and astrocytes, establishing that Olig genes couple neuronal and glial subtype specification.","method":"Genetic loss-of-function (Olig1/2 double-knockout mice), lineage tracing","journal":"Cell","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean genetic double-knockout with lineage tracing, replicated across multiple cell types, foundational study","pmids":["11955447"],"is_preprint":false},{"year":2005,"finding":"Olig1 is required for oligodendrocyte myelinogenesis specifically in the brain (not spinal cord); Olig1-null mice show abolished expression of myelin-specific genes (Mbp, Plp1, Mag), failure of multilamellar myelin wrapping around axons despite axonal contact, and Olig1 suppresses astrocyte-specific Gfap expression. Oligodendrocyte progenitor formation is unaffected.","method":"Olig1-null mouse genetic knockout, gene expression analysis, electron microscopy","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — clean knockout with multiple orthogonal readouts (molecular, ultrastructural, behavioral), regional specificity established","pmids":["15703389"],"is_preprint":false},{"year":2007,"finding":"OLIG1 physically associates with the transcription factor SOX10, and the OLIG1/SOX10 complex activates myelin basic protein (mbp) transcription through conserved DNA sequence motifs in the mbp promoter. In contrast, OLIG2 does not bind SOX10 in zebrafish, though both OLIG1 and OLIG2 bind SOX10 in mouse.","method":"Co-immunoprecipitation (physical interaction), promoter-reporter assays (transcriptional activation), zebrafish and mouse models","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — physical interaction confirmed by Co-IP, functional transcriptional activation via promoter assay, cross-species validation","pmids":["18160645"],"is_preprint":false},{"year":2007,"finding":"BMP2 and BMP4 inhibit oligodendrocyte differentiation of adult OPCs by downregulating olig1 and olig2 expression; overexpression of olig1 alone blocked BMP-induced astrocyte differentiation, but overexpression of both olig1 and olig2 together was required to rescue oligodendrocyte differentiation from BMP inhibition.","method":"Adult OPC culture, BMP treatment, overexpression of olig1/olig2 via transfection, immunostaining","journal":"Stem cells","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain-of-function rescue experiment with defined pathway placement (BMP→ID4→olig1/2 suppression), single lab","pmids":["17872503"],"is_preprint":false},{"year":2010,"finding":"Olig1 and Olig2 triplication in the Ts65Dn Down syndrome mouse model causes overproduction of GABAergic interneurons and imbalance of excitatory/inhibitory tone; normalization of Olig1/Olig2 gene dosage (from 3 copies to 2) rescues the inhibitory neuron phenotype.","method":"Genetic dosage normalization in Ts65Dn mice, cell counting, electrophysiology","journal":"Nature neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Strong — genetic rescue by dosage normalization with defined cellular and physiological phenotype, directly links Olig1/2 triplication to interneuron overproduction","pmids":["20639873"],"is_preprint":false},{"year":2012,"finding":"Olig1 is phosphorylated at serine 138 in the helix-loop-helix domain; this phosphorylated form resides in the cytosol. A serine-to-alanine mutation (S138A) restricts Olig1 to the nucleus and permits MBP expression but limits membrane expansion, while a serine-to-aspartate (phosphomimetic S138D) mutation causes cytoplasmic localization and enhances membrane expansion and oligodendrocyte maturation.","method":"Site-directed mutagenesis, nuclear-specific Olig1 expression in Olig1-null OPCs, phosphorylation site identification, cell morphology quantification","journal":"Glia","confidence":"High","confidence_rationale":"Tier 1 / Moderate — mutagenesis of specific phosphorylation site with rescue in null background and defined morphological phenotype, single lab but multiple orthogonal approaches","pmids":["22639060"],"is_preprint":false},{"year":2013,"finding":"OLIG1 functions as a Smad cofactor in TGF-β signaling: OLIG1 physically interacts with Smad2/3 (via the L3 loop of Smad3), and this interaction is regulated by the prolyl isomerase Pin1. Knockdown of OLIG1 attenuates TGF-β-induced cell motility (migration and wound healing) but has no effect on BMP-induced motility, TGF-β-induced cytostasis, or epithelial-mesenchymal transition.","method":"Co-immunoprecipitation (Smad2/3–Olig1 interaction), siRNA knockdown, chamber migration and wound healing assays, Pin1 knockdown, synthetic peptide inhibition","journal":"The Journal of biological chemistry","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — reciprocal Co-IP, functional knockdown with specific phenotypic readout, mechanistic dissection with peptide inhibitor, single lab with multiple orthogonal methods","pmids":["23720758"],"is_preprint":false},{"year":2014,"finding":"Olig1 directly represses the Dlx1/2 I12b intergenic enhancer, and Dlx1/2 function genetically downstream of Olig1. Olig1 deletion in mice causes ectopic Dlx1/2 upregulation in the ventral medial ganglionic eminences and a ~30% increase in adult cortical GABAergic interneuron numbers.","method":"Olig1 conditional knockout mice, chromatin immunoprecipitation (Olig1 binding to Dlx1/2 I12b enhancer), genetic epistasis (Dlx1/2 downstream of Olig1), cell counting","journal":"Neuron","confidence":"High","confidence_rationale":"Tier 1–2 / Strong — ChIP demonstrating direct enhancer binding, genetic epistasis established, loss-of-function phenotype quantified, multiple orthogonal methods","pmids":["24507192"],"is_preprint":false},{"year":2014,"finding":"TIP30 sequesters Olig1 in the cytoplasm by direct protein–protein interaction, preventing its nuclear translocation and thereby inhibiting OPC differentiation; TIP30 overexpression inhibits OPC stage progression while TIP30 knockdown enhances oligodendroglial differentiation and increases nuclear Olig1.","method":"Co-immunoprecipitation (TIP30–Olig1 interaction), TIP30 overexpression/knockdown in primary OPC cultures, subcellular localization by immunostaining, cuprizone demyelination model","journal":"Glia","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — Co-IP plus gain/loss-of-function with defined localization and differentiation phenotype, single lab","pmids":["25530119"],"is_preprint":false},{"year":2015,"finding":"Olig1 acetylation at Lys150 (human Olig1) drives nuclear-to-cytoplasmic translocation. The acetyltransferase CBP (CREB-binding protein) and deacetylases HDAC1, HDAC3, and HDAC10 regulate this modification. Acetylation decreases Olig1 chromatin association, increases interaction with ID2, and facilitates cytoplasmic retention in mature oligodendrocytes. Three functional nuclear export sequences (NES) were identified in the bHLH domain.","method":"Identification of acetylation site (Lys150) by mutagenesis, CBP/HDAC overexpression/knockdown, chromatin association assays, Co-IP (Olig1–ID2 interaction), subcellular fractionation/immunostaining in mouse and rat oligodendrocytes","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — specific residue mutagenesis, identified writer (CBP) and erasers (HDAC1/3/10), interaction partner (ID2), and functional consequence on chromatin/localization, multiple orthogonal methods in single lab","pmids":["26631469"],"is_preprint":false},{"year":2015,"finding":"Olig1 is required for oligodendrocyte progenitor cell commitment and differentiation in the brain corpus callosum, with hypomyelination persisting into adulthood. In the spinal cord, compensatory upregulation of Olig2 protein (not seen in brain) partially rescues the deficit, explaining the regional difference in Olig1 requirement.","method":"Olig1-null mouse analysis, Olig2 protein quantification by Western blot and immunostaining, myelination assessment by electron microscopy and immunostaining","journal":"The Journal of neuroscience","confidence":"High","confidence_rationale":"Tier 2 / Moderate — genetic knockout with regional comparison, Olig2 compensatory upregulation as mechanistic explanation, multiple readouts","pmids":["25762682"],"is_preprint":false},{"year":2010,"finding":"Olig1 protein translocates from the cytoplasm to the nucleus in EAE (demyelination) rat brains, and progesterone treatment increases the proportion of cells showing nuclear Olig1 localization, correlating with enhanced remyelination.","method":"Immunostaining for Olig1 subcellular localization in EAE rat brain, electron microscopy for myelin assessment, progesterone injection paradigm","journal":"Neuroscience letters","confidence":"Low","confidence_rationale":"Tier 3 / Weak — single lab, correlative localization data without direct mechanistic manipulation of Olig1","pmids":["20381586"],"is_preprint":false},{"year":2010,"finding":"Olig1 and ID4 directly interact and form a dimer in living cells; the Olig1–ID4 complex localizes to the cytoplasm (whereas Olig1 alone is nuclear and ID4 alone is cytoplasmic), indicating that ID4 blocks nuclear transport of Olig1.","method":"Bimolecular fluorescence complementation (BiFC) in SW1116 cells, EGFP/DsRed2 fusion protein co-expression and colocalization","journal":"Molecular biology reports","confidence":"Medium","confidence_rationale":"Tier 2 / Weak — direct visualization of protein–protein interaction in living cells with defined localization consequence, single lab, single method","pmids":["21132377"],"is_preprint":false},{"year":2017,"finding":"Olig1 function is required downstream of Noggin (BMP antagonism) for OPC production after neonatal stroke; in postnatal neural progenitors, Noggin governs OL versus interneuron fate through Olig1-mediated repression of Dlx1/2 transcription factors. Olig1-null neonatal mice show hypomyelination and replacement of OPCs with proliferating neuronal precursors and GABAergic interneurons in damaged white matter.","method":"Olig1-null mice subjected to neonatal stroke, postnatal neural progenitor cultures with Noggin treatment, immunostaining for lineage markers","journal":"Annals of neurology","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — genetic loss-of-function with defined pathway placement (Noggin→Olig1→Dlx1/2 repression), in vitro and in vivo, single lab","pmids":["28253550"],"is_preprint":false},{"year":2017,"finding":"HMGN proteins regulate OLIG1 and OLIG2 expression through chromatin dynamics: loss of HMGNs increases histone H1 chromatin binding at Olig1/2 loci, recruiting the methyltransferase EZH2 and elevating H3K27me3 (repressive mark), thereby reducing Olig1/2 expression and impeding oligodendrocyte lineage specification.","method":"HMGN knockout ESC differentiation assays, ChIP for H1/EZH2/H3K27me3 at Olig1/2 loci, gene expression analysis, mouse behavioral and histological phenotyping","journal":"Nucleic acids research","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — ChIP demonstrating epigenetic mechanism at Olig1 locus, ESC differentiation and in vivo mouse phenotype, single lab","pmids":["27923998"],"is_preprint":false},{"year":2021,"finding":"Quetiapine upregulates Olig1 expression and promotes nuclear-to-cytoplasmic translocation of Olig1, where cytoplasmic Olig1 (not as transcription factor) drives oligodendroglial membrane expansion and maturation. Quetiapine also reverses GPR17-mediated inhibition of oligodendroglial morphological maturation, with Olig1 identified as upstream regulator of GPR17.","method":"Primary oligodendrocyte cultures, quetiapine treatment, Olig1 subcellular localization by immunostaining, morphological quantification, GPR17 expression analysis","journal":"Glia","confidence":"Low","confidence_rationale":"Tier 3 / Weak — pharmacological manipulation without direct genetic proof of Olig1 as mediator, single lab, correlative mechanism","pmids":["33660902"],"is_preprint":false},{"year":2024,"finding":"Olig1 promotes axonal regeneration in spinal motor neurons; Olig1 overexpression facilitates axonal regeneration in multiple injury models while deletion has the opposite effect. Olig1 acts at least partially through transcriptional regulation of the neurite extension factor Nrsn1.","method":"Transcriptomic profiling of motor neurons with differential regenerative capacity, Olig1 overexpression/deletion in regeneration models, identification of Nrsn1 as downstream target by differential gene expression and functional validation","journal":"Cell reports","confidence":"Medium","confidence_rationale":"Tier 2 / Moderate — gain- and loss-of-function in multiple models with defined downstream target (Nrsn1), single lab","pmids":["39002126"],"is_preprint":false},{"year":2025,"finding":"Olig1 and Olig2 coordinately regulate cortical astrocyte maturation by directly binding the Bmp7 enhancer and repressing Bmp7 expression; genetic ablation of both Olig1 and Olig2 results in defective astrocyte morphology and immature gene expression, while Bmp7 overexpression in vivo replicates this phenotype.","method":"Olig1/2 double knockout mice, single-cell RNA sequencing, ChIP/CUT&Tag for Olig1/2 binding at Bmp7 enhancer, Bmp7 overexpression in vivo","journal":"Journal of genetics and genomics","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — direct enhancer binding demonstrated, genetic epistasis via Bmp7 overexpression phenocopy, scRNA-seq, single lab with multiple orthogonal methods","pmids":["40139307"],"is_preprint":false},{"year":2025,"finding":"Olig1 and Olig2 coordinately regulate Tri-IPC fate specification in cortical gliogenesis by activating OPC specification while repressing OBIN-IPC generation through direct binding to multiple conserved enhancer elements of Gsx2, suppressing its expression; Olig1/2 genetic ablation redirects progenitors from OPC to OBIN-IPC fate with Gsx2 upregulation.","method":"Olig1/2 double knockout mouse genetics, CUT&Tag-seq for Olig1/2 binding at Gsx2 enhancers, single-cell transcriptomics, in vivo mutagenesis","journal":"Nature communications","confidence":"High","confidence_rationale":"Tier 1–2 / Moderate — genome-wide binding (CUT&Tag) at specific enhancers, genetic loss-of-function with defined cell fate switch, multi-omics, single lab with multiple orthogonal methods","pmids":["41193423"],"is_preprint":false},{"year":2025,"finding":"OLIG1 and OLIG2 drive GBM tumor cell proliferation by directly binding to promoter regions of cyclins (Cdk4, Ccne2, Ccnd3, Ccnd1), marked by H3K4me3 (active histone mark), leading to transcriptional activation; Olig1/2 knockout reduces proliferation but does not suppress tumor initiation or migration.","method":"CRISPR/Cas9 Olig1/2 knockout in GBM mouse model, CUT&Tag-seq for Olig1/2 binding at cyclin promoters, H3K4me3 ChIP, tumor proliferation assays","journal":"Genes","confidence":"Medium","confidence_rationale":"Tier 1–2 / Moderate — direct promoter binding by CUT&Tag with histone mark validation, genetic knockout with defined proliferation phenotype, single lab","pmids":["40428395"],"is_preprint":false}],"current_model":"OLIG1 is a bHLH transcription factor that promotes oligodendrocyte differentiation and myelinogenesis (primarily in brain) by activating myelin gene transcription (Mbp, Plp1, Mag) in complex with SOX10, repressing interneuron production via direct suppression of Dlx1/2 enhancers, and regulating astrocyte maturation through Bmp7 enhancer repression; its activity is controlled by phosphorylation at Ser138 and acetylation at Lys150 (regulated by CBP/HDAC1/3/10), which govern nuclear-cytoplasmic shuttling—nuclear Olig1 drives myelin gene transcription while phosphorylated cytoplasmic Olig1 promotes membrane expansion—and its interaction partners include SOX10, Smad2/3 (as a TGF-β co-factor regulated by Pin1), ID2, ID4 (which sequesters Olig1 in the cytoplasm), and TIP30 (which blocks nuclear translocation)."},"narrative":{"mechanistic_narrative":"OLIG1 is a basic helix-loop-helix transcription factor that operates at the crossroads of neuronal versus glial fate decisions and drives the oligodendrocyte differentiation and myelination program in the CNS [PMID:11955447, PMID:15703389]. In progenitor specification, OLIG1 (with OLIG2) directs cells toward the oligodendrocyte lineage and away from interneuron fates: it directly binds and represses the Dlx1/2 I12b intergenic enhancer to restrain cortical GABAergic interneuron production [PMID:24507192], represses the Gsx2 enhancers to bias Tri-IPC progenitors toward OPC rather than OBIN-IPC fate [PMID:41193423], and is required downstream of BMP antagonism (Noggin) for OPC production after injury [PMID:28253550]. During myelinogenesis it activates myelin-specific genes (Mbp, Plp1, Mag) and suppresses the astrocyte gene Gfap, with brain-specific requirement because spinal cord deficits are buffered by compensatory OLIG2 upregulation [PMID:15703389, PMID:25762682]; mechanistically, OLIG1 partners with SOX10 to transactivate the mbp promoter [PMID:18160645]. OLIG1 activity is governed by regulated nuclear-cytoplasmic shuttling: phosphorylation at Ser138 and acetylation at Lys150 (written by CBP and erased by HDAC1/3/10) drive nuclear export, where cytoplasmic OLIG1 promotes oligodendroglial membrane expansion while nuclear OLIG1 sustains myelin gene transcription [PMID:22639060, PMID:26631469]. Cytoplasmic sequestration is enforced by direct binding partners including ID2, ID4, and TIP30, which block OLIG1 nuclear translocation [PMID:26631469, PMID:21132377, PMID:25530119]. Beyond oligodendrocytes, OLIG1 acts as a Smad2/3 cofactor regulated by Pin1 to promote TGF-β-induced cell motility [PMID:23720758] and, with OLIG2, represses a Bmp7 enhancer to control astrocyte maturation [PMID:40139307].","teleology":[{"year":2002,"claim":"Established the foundational role of Olig genes in coupling neuronal and glial subtype specification, answering whether a single factor class governs both motoneuron and oligodendrocyte production.","evidence":"Olig1/2 double-knockout mice with lineage tracing in the spinal cord pMN domain","pmids":["11955447"],"confidence":"High","gaps":["Did not separate OLIG1- from OLIG2-specific contributions","Direct transcriptional targets not identified"]},{"year":2005,"claim":"Defined OLIG1 as a dedicated driver of brain myelinogenesis, distinguishing OPC formation from the subsequent differentiation/myelin-wrapping step it controls.","evidence":"Olig1-null mice with myelin gene expression analysis and electron microscopy","pmids":["15703389"],"confidence":"High","gaps":["Direct DNA targets in myelin gene loci not mapped","Basis of brain vs spinal cord specificity unexplained at this stage"]},{"year":2007,"claim":"Identified a direct molecular mechanism for myelin gene activation by showing OLIG1 forms a transactivating complex with SOX10 on the mbp promoter.","evidence":"Co-IP and promoter-reporter assays in zebrafish and mouse","pmids":["18160645"],"confidence":"High","gaps":["Cross-species divergence in OLIG2-SOX10 binding leaves complex stoichiometry unresolved","Full set of co-regulated promoters not defined"]},{"year":2007,"claim":"Placed Olig1/2 downstream of BMP signaling in the OPC-versus-astrocyte fate decision, clarifying how extracellular cues gate the oligodendrocyte program.","evidence":"Adult OPC culture with BMP treatment and olig1/olig2 overexpression rescue","pmids":["17872503"],"confidence":"Medium","gaps":["Requires both Olig1 and Olig2 for full rescue, so Olig1-specific sufficiency unclear","Single lab"]},{"year":2010,"claim":"Connected Olig1/2 gene dosage to interneuron number, demonstrating that triplication causes excitatory/inhibitory imbalance reversible by dosage normalization.","evidence":"Genetic dosage normalization in Ts65Dn Down syndrome mice with cell counting and electrophysiology","pmids":["20639873"],"confidence":"High","gaps":["Did not resolve direct transcriptional mechanism of interneuron suppression","Olig1 vs Olig2 individual dosage contribution not separated"]},{"year":2010,"claim":"Provided first evidence that OLIG1 subcellular localization is regulated and correlates with remyelination, and that ID4 directly blocks its nuclear transport.","evidence":"Olig1 immunolocalization in EAE rat brain with progesterone treatment; BiFC of Olig1-ID4 dimer in cells","pmids":["20381586","21132377"],"confidence":"Low","gaps":["EAE/progesterone data are correlative without direct Olig1 manipulation","BiFC is single-method without functional differentiation readout"]},{"year":2012,"claim":"Identified Ser138 phosphorylation as a switch controlling OLIG1 nuclear-cytoplasmic distribution and uncoupling myelin gene transcription from membrane expansion.","evidence":"Phosphosite identification and S138A/S138D mutagenesis with rescue in Olig1-null OPCs and morphology quantification","pmids":["22639060"],"confidence":"High","gaps":["Kinase responsible for Ser138 phosphorylation not identified","Cytoplasmic effector mechanism for membrane expansion undefined"]},{"year":2013,"claim":"Revealed a non-glial role for OLIG1 as a Smad2/3 cofactor in TGF-β-driven cell motility, regulated by Pin1.","evidence":"Reciprocal Co-IP mapping interaction to the Smad3 L3 loop, siRNA knockdown, migration/wound-healing assays, peptide inhibition","pmids":["23720758"],"confidence":"High","gaps":["Target genes mediating motility not identified","Relevance to oligodendrocyte biology not established"]},{"year":2014,"claim":"Demonstrated that OLIG1 directly represses the Dlx1/2 enhancer to limit GABAergic interneuron production, providing the molecular basis for the neuron/glia fate switch.","evidence":"Olig1 conditional knockout, ChIP at the Dlx1/2 I12b enhancer, genetic epistasis, cell counting","pmids":["24507192"],"confidence":"High","gaps":["Co-repressor complex at the enhancer not characterized","Interplay with OLIG2 at this locus not resolved"]},{"year":2014,"claim":"Identified TIP30 as a direct cytoplasmic sequestration factor controlling the timing of OLIG1 nuclear entry and OPC differentiation.","evidence":"Co-IP, TIP30 gain/loss-of-function in primary OPCs, localization imaging, cuprizone demyelination model","pmids":["25530119"],"confidence":"Medium","gaps":["Reciprocal Co-IP not reported","Relationship between TIP30 and the phospho/acetyl shuttling code unknown"]},{"year":2015,"claim":"Defined an acetylation-based export code (Lys150, CBP writer, HDAC1/3/10 erasers, NES signals) that reduces chromatin association and routes OLIG1 to the cytoplasm via ID2 binding in mature oligodendrocytes.","evidence":"Lys150 mutagenesis, CBP/HDAC manipulation, chromatin association assays, Olig1-ID2 Co-IP, fractionation in mouse/rat oligodendrocytes","pmids":["26631469"],"confidence":"High","gaps":["Crosstalk between Ser138 phosphorylation and Lys150 acetylation not resolved","In vivo significance of NES mutants not tested"]},{"year":2015,"claim":"Explained the brain-specific requirement for OLIG1 by showing compensatory OLIG2 protein upregulation rescues spinal but not brain myelination deficits.","evidence":"Olig1-null mouse analysis with OLIG2 quantification, electron microscopy, immunostaining in corpus callosum","pmids":["25762682"],"confidence":"High","gaps":["Mechanism restricting OLIG2 compensation to spinal cord unknown","Long-term functional myelin consequences not fully characterized"]},{"year":2017,"claim":"Integrated OLIG1 into the BMP-antagonism injury response, positioning it downstream of Noggin to govern OL-versus-interneuron fate via Dlx1/2 repression after stroke.","evidence":"Olig1-null neonatal stroke model and Noggin-treated postnatal progenitor cultures with lineage marker staining","pmids":["28253550"],"confidence":"Medium","gaps":["Direct link between Noggin signaling and Olig1 regulation not mapped molecularly","Single lab"]},{"year":2017,"claim":"Showed that Olig1/2 expression itself is set by chromatin state, with HMGN proteins preventing EZH2/H3K27me3-mediated silencing of the loci.","evidence":"HMGN-knockout ESC differentiation, ChIP for H1/EZH2/H3K27me3 at Olig1/2 loci, mouse phenotyping","pmids":["27923998"],"confidence":"Medium","gaps":["Olig1- vs Olig2-locus-specific effects not separated","Upstream signals controlling HMGN occupancy unknown"]},{"year":2021,"claim":"Linked pharmacological induction of cytoplasmic OLIG1 to oligodendroglial membrane maturation and GPR17 regulation, supporting the cytoplasmic non-transcriptional function.","evidence":"Quetiapine treatment of primary oligodendrocytes with localization imaging and GPR17 analysis","pmids":["33660902"],"confidence":"Low","gaps":["No direct genetic proof that Olig1 mediates quetiapine effect","Mechanism of GPR17 regulation by Olig1 not defined"]},{"year":2024,"claim":"Extended OLIG1 function to neuronal axon biology, showing it promotes spinal motor neuron axonal regeneration partly via transcriptional control of Nrsn1.","evidence":"Transcriptomics of motor neurons, Olig1 overexpression/deletion in regeneration models, Nrsn1 functional validation","pmids":["39002126"],"confidence":"Medium","gaps":["Direct Olig1 binding at Nrsn1 not demonstrated","Full regenerative target set unknown"]},{"year":2025,"claim":"Mapped genome-wide enhancer/promoter binding establishing OLIG1/2 as direct repressors (Bmp7, Gsx2) in astrocyte maturation and gliogenic fate and direct activators (cyclins) driving GBM proliferation.","evidence":"Olig1/2 double-knockout mice, CUT&Tag-seq, scRNA-seq, H3K4me3 ChIP, in vivo overexpression phenocopy and CRISPR knockout in GBM","pmids":["40139307","41193423","40428395"],"confidence":"High","gaps":["OLIG1-specific versus OLIG2-specific binding contributions not separated","Switch between repressive and activating modes at different loci not mechanistically explained"]},{"year":null,"claim":"How the phosphorylation (Ser138) and acetylation (Lys150) shuttling codes are integrated with the sequestration partners (ID2/ID4/TIP30) and upstream signals to time the nuclear-to-cytoplasmic transition during differentiation remains unresolved.","evidence":"","pmids":[],"confidence":"High","gaps":["No unified model linking PTM code to partner binding","Upstream kinase/signaling inputs not identified","In vivo significance of cytoplasmic OLIG1 function not genetically dissected"]}],"mechanism_profile":{"molecular_activity":[{"term_id":"GO:0140110","term_label":"transcription regulator activity","supporting_discovery_ids":[1,2,7,17,18,19]},{"term_id":"GO:0003677","term_label":"DNA binding","supporting_discovery_ids":[7,17,18,19]},{"term_id":"GO:0060089","term_label":"molecular transducer activity","supporting_discovery_ids":[6]}],"localization":[{"term_id":"GO:0005634","term_label":"nucleus","supporting_discovery_ids":[5,8,9,12]},{"term_id":"GO:0005829","term_label":"cytosol","supporting_discovery_ids":[5,8,9,12]}],"pathway":[{"term_id":"R-HSA-1266738","term_label":"Developmental Biology","supporting_discovery_ids":[0,1,7,17,18]},{"term_id":"R-HSA-74160","term_label":"Gene expression (Transcription)","supporting_discovery_ids":[2,7,17,18,19]},{"term_id":"R-HSA-162582","term_label":"Signal Transduction","supporting_discovery_ids":[6,3,13]}],"complexes":[],"partners":["SOX10","SMAD2","SMAD3","ID2","ID4","TIP30","OLIG2","PIN1"],"other_free_text":[]}},"prefetch_data":{"uniprot":{"accession":"Q8TAK6","full_name":"Oligodendrocyte transcription factor 1","aliases":["Class B basic helix-loop-helix protein 6","bHLHb6","Class E basic helix-loop-helix protein 21","bHLHe21"],"length_aa":271,"mass_kda":27.9,"function":"Promotes formation and maturation of oligodendrocytes, especially within the brain. Cooperates with OLIG2 to establish the pMN domain of the embryonic neural tube (By similarity)","subcellular_location":"Nucleus","url":"https://www.uniprot.org/uniprotkb/Q8TAK6/entry"},"depmap":{"release":"DepMap","has_data":true,"is_common_essential":false,"resolved_as":"","url":"https://depmap.org/portal/gene/OLIG1","classification":"Not Classified","n_dependent_lines":7,"n_total_lines":1208,"dependency_fraction":0.005794701986754967},"opencell":{"profiled":false,"resolved_as":"","ensg_id":"","cell_line_id":"","localizations":[],"interactors":[],"url":"https://opencell.sf.czbiohub.org/search/OLIG1","total_profiled":1310},"omim":[{"mim_id":"614059","title":"MICRO RNA 338; MIR338","url":"https://www.omim.org/entry/614059"},{"mim_id":"611500","title":"MICRO RNA 219-1; MIR219-1","url":"https://www.omim.org/entry/611500"},{"mim_id":"606386","title":"OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 2; OLIG2","url":"https://www.omim.org/entry/606386"},{"mim_id":"606385","title":"OLIGODENDROCYTE LINEAGE TRANSCRIPTION FACTOR 1; OLIG1","url":"https://www.omim.org/entry/606385"},{"mim_id":"606241","title":"DICER 1, RIBONUCLEASE III; DICER1","url":"https://www.omim.org/entry/606241"}],"hpa":{"profiled":true,"resolved_as":"","reliability":"","locations":[],"tissue_specificity":"Tissue enriched","tissue_distribution":"Detected in some","driving_tissues":[{"tissue":"brain","ntpm":228.3}],"url":"https://www.proteinatlas.org/search/OLIG1"},"hgnc":{"alias_symbol":["BHLHB6","bHLHe21"],"prev_symbol":[]},"alphafold":{"accession":"Q8TAK6","domains":[{"cath_id":"4.10.280,4.10.280","chopping":"98-139_149-174","consensus_level":"high","plddt":91.5631,"start":98,"end":174}],"viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TAK6","model_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TAK6-F1-model_v6.cif","pae_url":"https://alphafold.ebi.ac.uk/files/AF-Q8TAK6-F1-predicted_aligned_error_v6.png","plddt_mean":59.25},"mouse_models":{"mgi_url":"https://www.informatics.jax.org/marker/summary?nomen=OLIG1","jax_strain_url":"https://www.jax.org/strain/search?query=OLIG1"},"sequence":{"accession":"Q8TAK6","fasta_url":"https://rest.uniprot.org/uniprotkb/Q8TAK6.fasta","uniprot_url":"https://www.uniprot.org/uniprotkb/Q8TAK6/entry","alphafold_viewer_url":"https://alphafold.ebi.ac.uk/entry/Q8TAK6"}},"corpus_meta":[{"pmid":"11955447","id":"PMC_11955447","title":"The bHLH transcription factors OLIG2 and OLIG1 couple neuronal and glial subtype specification.","date":"2002","source":"Cell","url":"https://pubmed.ncbi.nlm.nih.gov/11955447","citation_count":847,"is_preprint":false},{"pmid":"15703389","id":"PMC_15703389","title":"Myelinogenesis and axonal recognition by oligodendrocytes in brain are uncoupled in Olig1-null mice.","date":"2005","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/15703389","citation_count":214,"is_preprint":false},{"pmid":"20639873","id":"PMC_20639873","title":"Olig1 and Olig2 triplication causes developmental brain defects in Down syndrome.","date":"2010","source":"Nature neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/20639873","citation_count":180,"is_preprint":false},{"pmid":"18160645","id":"PMC_18160645","title":"Olig1 and Sox10 interact synergistically to drive myelin basic protein transcription in oligodendrocytes.","date":"2007","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/18160645","citation_count":143,"is_preprint":false},{"pmid":"17872503","id":"PMC_17872503","title":"Bone morphogenetic protein signaling and olig1/2 interact to regulate the differentiation and maturation of adult oligodendrocyte precursor cells.","date":"2007","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/17872503","citation_count":112,"is_preprint":false},{"pmid":"25762682","id":"PMC_25762682","title":"Olig1 function is required for oligodendrocyte differentiation in the mouse brain.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/25762682","citation_count":94,"is_preprint":false},{"pmid":"14575240","id":"PMC_14575240","title":"Expression of the oligodendroglial lineage-associated markers Olig1 and Olig2 in different types of human gliomas.","date":"2003","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/14575240","citation_count":72,"is_preprint":false},{"pmid":"24507192","id":"PMC_24507192","title":"Olig1 function is required to repress dlx1/2 and interneuron production in Mammalian brain.","date":"2014","source":"Neuron","url":"https://pubmed.ncbi.nlm.nih.gov/24507192","citation_count":58,"is_preprint":false},{"pmid":"26631469","id":"PMC_26631469","title":"Olig1 Acetylation and Nuclear Export Mediate Oligodendrocyte Development.","date":"2015","source":"The Journal of neuroscience : the official journal of the Society for Neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/26631469","citation_count":50,"is_preprint":false},{"pmid":"20381586","id":"PMC_20381586","title":"Progesterone attenuates neurological behavioral deficits of experimental autoimmune encephalomyelitis through remyelination with nucleus-sublocalized Olig1 protein.","date":"2010","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/20381586","citation_count":50,"is_preprint":false},{"pmid":"22639060","id":"PMC_22639060","title":"Phosphorylated olig1 localizes to the cytosol of oligodendrocytes and promotes membrane expansion and maturation.","date":"2012","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/22639060","citation_count":49,"is_preprint":false},{"pmid":"19253391","id":"PMC_19253391","title":"olig1 Expression identifies developing oligodendrocytes in zebrafish and requires hedgehog and notch signaling.","date":"2009","source":"Developmental dynamics : an official publication of the American Association of Anatomists","url":"https://pubmed.ncbi.nlm.nih.gov/19253391","citation_count":38,"is_preprint":false},{"pmid":"21446039","id":"PMC_21446039","title":"Olig1 is expressed in human oligodendrocytes during maturation and regeneration.","date":"2011","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/21446039","citation_count":38,"is_preprint":false},{"pmid":"27923998","id":"PMC_27923998","title":"Interplay between H1 and HMGN epigenetically regulates OLIG1&2 expression and oligodendrocyte differentiation.","date":"2017","source":"Nucleic acids research","url":"https://pubmed.ncbi.nlm.nih.gov/27923998","citation_count":36,"is_preprint":false},{"pmid":"23615187","id":"PMC_23615187","title":"Increased nuclear Olig1-expression in the pregenual anterior cingulate white matter of patients with major depression: a regenerative attempt to compensate oligodendrocyte loss?","date":"2013","source":"Journal of psychiatric research","url":"https://pubmed.ncbi.nlm.nih.gov/23615187","citation_count":31,"is_preprint":false},{"pmid":"24423059","id":"PMC_24423059","title":"New Olig1 null mice confirm a non-essential role for Olig1 in oligodendrocyte development.","date":"2014","source":"BMC neuroscience","url":"https://pubmed.ncbi.nlm.nih.gov/24423059","citation_count":28,"is_preprint":false},{"pmid":"14989603","id":"PMC_14989603","title":"Immunolocalization of the oligodendrocyte transcription factor 1 (Olig1) in brain tumors.","date":"2004","source":"Journal of neuropathology and experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/14989603","citation_count":28,"is_preprint":false},{"pmid":"15536179","id":"PMC_15536179","title":"Transient expression of Olig1 initiates the differentiation of neural stem cells into oligodendrocyte progenitor cells.","date":"2004","source":"Stem cells (Dayton, Ohio)","url":"https://pubmed.ncbi.nlm.nih.gov/15536179","citation_count":27,"is_preprint":false},{"pmid":"21206754","id":"PMC_21206754","title":"A systematic enhancer screen using lentivector transgenesis identifies conserved and non-conserved functional elements at the Olig1 and Olig2 locus.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/21206754","citation_count":27,"is_preprint":false},{"pmid":"22449475","id":"PMC_22449475","title":"Olig1 function is required for remyelination potential of transplanted neural progenitor cells in a model of viral-induced demyelination.","date":"2012","source":"Experimental neurology","url":"https://pubmed.ncbi.nlm.nih.gov/22449475","citation_count":25,"is_preprint":false},{"pmid":"21538562","id":"PMC_21538562","title":"Differential and cooperative actions of Olig1 and Olig2 transcription factors on immature proliferating cells after contusive spinal cord injury.","date":"2011","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/21538562","citation_count":24,"is_preprint":false},{"pmid":"25435330","id":"PMC_25435330","title":"Effect of OLIG1 on the development of oligodendrocytes and myelination in a neonatal rat PVL model induced by hypoxia-ischemia.","date":"2014","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/25435330","citation_count":24,"is_preprint":false},{"pmid":"15164981","id":"PMC_15164981","title":"Analysis of the bHLH transcription factors Olig1 and Olig2 in brain tumors.","date":"2004","source":"Journal of neuro-oncology","url":"https://pubmed.ncbi.nlm.nih.gov/15164981","citation_count":23,"is_preprint":false},{"pmid":"23720758","id":"PMC_23720758","title":"Oligodendrocyte transcription factor 1 (Olig1) is a Smad cofactor involved in cell motility induced by transforming growth factor-β.","date":"2013","source":"The Journal of biological chemistry","url":"https://pubmed.ncbi.nlm.nih.gov/23720758","citation_count":23,"is_preprint":false},{"pmid":"28464811","id":"PMC_28464811","title":"Effect of catalpol on remyelination through experimental autoimmune encephalomyelitis acting to promote Olig1 and Olig2 expressions in mice.","date":"2017","source":"BMC complementary and alternative medicine","url":"https://pubmed.ncbi.nlm.nih.gov/28464811","citation_count":15,"is_preprint":false},{"pmid":"36634201","id":"PMC_36634201","title":"Olig1/2-Expressing Intermediate Lineage Progenitors Are Predisposed to PTEN/p53-Loss-Induced Gliomagenesis and Harbor Specific Therapeutic Vulnerabilities.","date":"2023","source":"Cancer research","url":"https://pubmed.ncbi.nlm.nih.gov/36634201","citation_count":14,"is_preprint":false},{"pmid":"28253550","id":"PMC_28253550","title":"Olig1 is required for noggin-induced neonatal myelin repair.","date":"2017","source":"Annals of neurology","url":"https://pubmed.ncbi.nlm.nih.gov/28253550","citation_count":14,"is_preprint":false},{"pmid":"25530119","id":"PMC_25530119","title":"TIP30 inhibits oligodendrocyte precursor cell differentiation via cytoplasmic sequestration of Olig1.","date":"2014","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/25530119","citation_count":14,"is_preprint":false},{"pmid":"33925547","id":"PMC_33925547","title":"Identification of CRYAB+ KCNN3+ SOX9+ Astrocyte-Like and EGFR+ PDGFRA+ OLIG1+ Oligodendrocyte-Like Tumoral Cells in Diffuse IDH1-Mutant Gliomas and Implication of NOTCH1 Signalling in Their Genesis.","date":"2021","source":"Cancers","url":"https://pubmed.ncbi.nlm.nih.gov/33925547","citation_count":13,"is_preprint":false},{"pmid":"31702031","id":"PMC_31702031","title":"Effects of the transcription factor Olig1 on the differentiation and remyelination of oligodendrocyte precursor cells after focal cerebral ischemia in rats.","date":"2019","source":"Molecular medicine reports","url":"https://pubmed.ncbi.nlm.nih.gov/31702031","citation_count":13,"is_preprint":false},{"pmid":"20927333","id":"PMC_20927333","title":"Delayed onset of experimental autoimmune encephalomyelitis in Olig1 deficient mice.","date":"2010","source":"PloS one","url":"https://pubmed.ncbi.nlm.nih.gov/20927333","citation_count":12,"is_preprint":false},{"pmid":"33660902","id":"PMC_33660902","title":"Quetiapine promotes oligodendroglial process outgrowth and membrane expansion by orchestrating the effects of Olig1.","date":"2021","source":"Glia","url":"https://pubmed.ncbi.nlm.nih.gov/33660902","citation_count":10,"is_preprint":false},{"pmid":"34592910","id":"PMC_34592910","title":"The Shh/Gli1 signaling pathway regulates regeneration via transcription factor Olig1 expression after focal cerebral ischemia in rats.","date":"2021","source":"Neurological research","url":"https://pubmed.ncbi.nlm.nih.gov/34592910","citation_count":9,"is_preprint":false},{"pmid":"21132377","id":"PMC_21132377","title":"Olig1 and ID4 interactions in living cells visualized by bimolecular fluorescence complementation technique.","date":"2010","source":"Molecular biology reports","url":"https://pubmed.ncbi.nlm.nih.gov/21132377","citation_count":7,"is_preprint":false},{"pmid":"40139307","id":"PMC_40139307","title":"Coordinated regulation of cortical astrocyte maturation by OLIG1 and OLIG2 through BMP7 signaling modulation.","date":"2025","source":"Journal of genetics and genomics = Yi chuan xue bao","url":"https://pubmed.ncbi.nlm.nih.gov/40139307","citation_count":6,"is_preprint":false},{"pmid":"34165684","id":"PMC_34165684","title":"Extreme Glycemic Fluctuations Debilitate NRG1, ErbB Receptors and Olig1 Function: Association with Regeneration, Cognition and Mood Alterations During Diabetes.","date":"2021","source":"Molecular neurobiology","url":"https://pubmed.ncbi.nlm.nih.gov/34165684","citation_count":6,"is_preprint":false},{"pmid":"27143892","id":"PMC_27143892","title":"Olig1 expression pattern in neural cells during rat spinal cord development.","date":"2016","source":"Neuropsychiatric disease and treatment","url":"https://pubmed.ncbi.nlm.nih.gov/27143892","citation_count":5,"is_preprint":false},{"pmid":"18628665","id":"PMC_18628665","title":"Olig1 is downregulated in oligodendrocyte progenitor cell differentiation.","date":"2008","source":"Neuroreport","url":"https://pubmed.ncbi.nlm.nih.gov/18628665","citation_count":4,"is_preprint":false},{"pmid":"41193423","id":"PMC_41193423","title":"Olig1/2 Orchestrates Progenitor Cell Fates during Mammalian Cortical Gliogenesis and Gliomagenesis.","date":"2025","source":"Nature communications","url":"https://pubmed.ncbi.nlm.nih.gov/41193423","citation_count":3,"is_preprint":false},{"pmid":"40428395","id":"PMC_40428395","title":"Olig1/2 Drive Astrocytic Glioblastoma Proliferation Through Transcriptional Co-Regulation of Various Cyclins.","date":"2025","source":"Genes","url":"https://pubmed.ncbi.nlm.nih.gov/40428395","citation_count":3,"is_preprint":false},{"pmid":"27084689","id":"PMC_27084689","title":"Predominant neuronal differentiation of Olig1+ neural progenitors in forebrain cortex biased by β-catenin over-expression.","date":"2016","source":"Neuroscience letters","url":"https://pubmed.ncbi.nlm.nih.gov/27084689","citation_count":3,"is_preprint":false},{"pmid":"17171653","id":"PMC_17171653","title":"Oligodendroglial transcription factor (OLIG1 and OLIG2) mutations are not associated with Pelizaeus-Merzbacher-like leukodystrophy.","date":"2007","source":"American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics","url":"https://pubmed.ncbi.nlm.nih.gov/17171653","citation_count":2,"is_preprint":false},{"pmid":"39002126","id":"PMC_39002126","title":"Comparative transcriptomic profiling reveals a role for Olig1 in promoting axon regeneration.","date":"2024","source":"Cell reports","url":"https://pubmed.ncbi.nlm.nih.gov/39002126","citation_count":1,"is_preprint":false},{"pmid":"24941845","id":"PMC_24941845","title":"[Effect of Yishen Daluo Decoction on the expression of PLP, Olig1, and Olig2 in mice with experimental autoimmune encephalomyelitis].","date":"2014","source":"Zhongguo Zhong xi yi jie he za zhi Zhongguo Zhongxiyi jiehe zazhi = Chinese journal of integrated traditional and Western medicine","url":"https://pubmed.ncbi.nlm.nih.gov/24941845","citation_count":1,"is_preprint":false},{"pmid":null,"id":"bio_10.1101_2025.10.01.25337099","title":"A versatile data repository for GWAS summary statistics-based downstream genomic analysis of human complex traits","date":"2025-10-02","source":"bioRxiv","url":"https://doi.org/10.1101/2025.10.01.25337099","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.11.17.688163","title":"Dual Transcriptional Drivers of Immune Suppression in SACC:  <i>NOTCH1</i>  for Cellular and  <i>MYB</i>  for Humoral Immunity","date":"2025-11-17","source":"bioRxiv","url":"https://doi.org/10.1101/2025.11.17.688163","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.12.29.630486","title":"H3K4-H3K9 Histone Methylation Patterns and Oncofetal Developmental Networks as Drivers of Cell Fate Decisions in Pediatric High-Grade Gliomas","date":"2024-12-30","source":"bioRxiv","url":"https://doi.org/10.1101/2024.12.29.630486","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.09.20.677552","title":"Designing signaling environments to modulate neural progenitor cell differentiation with regulatory network models","date":"2025-09-21","source":"bioRxiv","url":"https://doi.org/10.1101/2025.09.20.677552","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2025.07.21.665861","title":"Hippocampal circuit-specific enhancement of GABA-inhibition caused by discrete gene regions in a Down syndrome model","date":"2025-07-24","source":"bioRxiv","url":"https://doi.org/10.1101/2025.07.21.665861","citation_count":0,"is_preprint":true},{"pmid":null,"id":"bio_10.1101_2024.11.11.623106","title":"Orchestrating the Acquisition of Oligodendrocyte Precursor Cell versus Olfactory Bulb Interneuron Fates through  <i>Olig1/2</i>  during Mammalian Cortical Gliogenesis and Gliomagenesis","date":"2024-11-14","source":"bioRxiv","url":"https://doi.org/10.1101/2024.11.11.623106","citation_count":0,"is_preprint":true}],"cost":{"stage1":{"model":"claude-sonnet-4-6","input_tokens":27146,"output_tokens":5352,"usd":0.080859,"stage1_stop_reason":"end_turn"},"stage2":{"model":"claude-opus-4-8","input_tokens":13717,"output_tokens":5150,"usd":0.098668,"stage2_stop_reason":"end_turn"},"total_usd":0.179527,"stage1_batch_id":"msgbatch_013a8chtv3AWyTqv4z4sEF4C","stage2_batch_id":"msgbatch_01AHsuW63vinsvuTgzmQ3n62","note":"batch pricing = 50% of standard"},"stage1_raw":"```json\n{\n  \"discoveries\": [\n    {\n      \"year\": 2002,\n      \"finding\": \"OLIG1 and OLIG2 are required for both motoneuron and oligodendrocyte specification in the spinal cord pMN domain; Olig1/2 double-mutant mice lose motoneurons and fail to generate oligodendrocytes, with pMN progenitors instead generating V2 interneurons and astrocytes, establishing that Olig genes couple neuronal and glial subtype specification.\",\n      \"method\": \"Genetic loss-of-function (Olig1/2 double-knockout mice), lineage tracing\",\n      \"journal\": \"Cell\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean genetic double-knockout with lineage tracing, replicated across multiple cell types, foundational study\",\n      \"pmids\": [\"11955447\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2005,\n      \"finding\": \"Olig1 is required for oligodendrocyte myelinogenesis specifically in the brain (not spinal cord); Olig1-null mice show abolished expression of myelin-specific genes (Mbp, Plp1, Mag), failure of multilamellar myelin wrapping around axons despite axonal contact, and Olig1 suppresses astrocyte-specific Gfap expression. Oligodendrocyte progenitor formation is unaffected.\",\n      \"method\": \"Olig1-null mouse genetic knockout, gene expression analysis, electron microscopy\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — clean knockout with multiple orthogonal readouts (molecular, ultrastructural, behavioral), regional specificity established\",\n      \"pmids\": [\"15703389\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"OLIG1 physically associates with the transcription factor SOX10, and the OLIG1/SOX10 complex activates myelin basic protein (mbp) transcription through conserved DNA sequence motifs in the mbp promoter. In contrast, OLIG2 does not bind SOX10 in zebrafish, though both OLIG1 and OLIG2 bind SOX10 in mouse.\",\n      \"method\": \"Co-immunoprecipitation (physical interaction), promoter-reporter assays (transcriptional activation), zebrafish and mouse models\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — physical interaction confirmed by Co-IP, functional transcriptional activation via promoter assay, cross-species validation\",\n      \"pmids\": [\"18160645\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2007,\n      \"finding\": \"BMP2 and BMP4 inhibit oligodendrocyte differentiation of adult OPCs by downregulating olig1 and olig2 expression; overexpression of olig1 alone blocked BMP-induced astrocyte differentiation, but overexpression of both olig1 and olig2 together was required to rescue oligodendrocyte differentiation from BMP inhibition.\",\n      \"method\": \"Adult OPC culture, BMP treatment, overexpression of olig1/olig2 via transfection, immunostaining\",\n      \"journal\": \"Stem cells\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain-of-function rescue experiment with defined pathway placement (BMP→ID4→olig1/2 suppression), single lab\",\n      \"pmids\": [\"17872503\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Olig1 and Olig2 triplication in the Ts65Dn Down syndrome mouse model causes overproduction of GABAergic interneurons and imbalance of excitatory/inhibitory tone; normalization of Olig1/Olig2 gene dosage (from 3 copies to 2) rescues the inhibitory neuron phenotype.\",\n      \"method\": \"Genetic dosage normalization in Ts65Dn mice, cell counting, electrophysiology\",\n      \"journal\": \"Nature neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Strong — genetic rescue by dosage normalization with defined cellular and physiological phenotype, directly links Olig1/2 triplication to interneuron overproduction\",\n      \"pmids\": [\"20639873\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2012,\n      \"finding\": \"Olig1 is phosphorylated at serine 138 in the helix-loop-helix domain; this phosphorylated form resides in the cytosol. A serine-to-alanine mutation (S138A) restricts Olig1 to the nucleus and permits MBP expression but limits membrane expansion, while a serine-to-aspartate (phosphomimetic S138D) mutation causes cytoplasmic localization and enhances membrane expansion and oligodendrocyte maturation.\",\n      \"method\": \"Site-directed mutagenesis, nuclear-specific Olig1 expression in Olig1-null OPCs, phosphorylation site identification, cell morphology quantification\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1 / Moderate — mutagenesis of specific phosphorylation site with rescue in null background and defined morphological phenotype, single lab but multiple orthogonal approaches\",\n      \"pmids\": [\"22639060\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2013,\n      \"finding\": \"OLIG1 functions as a Smad cofactor in TGF-β signaling: OLIG1 physically interacts with Smad2/3 (via the L3 loop of Smad3), and this interaction is regulated by the prolyl isomerase Pin1. Knockdown of OLIG1 attenuates TGF-β-induced cell motility (migration and wound healing) but has no effect on BMP-induced motility, TGF-β-induced cytostasis, or epithelial-mesenchymal transition.\",\n      \"method\": \"Co-immunoprecipitation (Smad2/3–Olig1 interaction), siRNA knockdown, chamber migration and wound healing assays, Pin1 knockdown, synthetic peptide inhibition\",\n      \"journal\": \"The Journal of biological chemistry\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — reciprocal Co-IP, functional knockdown with specific phenotypic readout, mechanistic dissection with peptide inhibitor, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"23720758\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"Olig1 directly represses the Dlx1/2 I12b intergenic enhancer, and Dlx1/2 function genetically downstream of Olig1. Olig1 deletion in mice causes ectopic Dlx1/2 upregulation in the ventral medial ganglionic eminences and a ~30% increase in adult cortical GABAergic interneuron numbers.\",\n      \"method\": \"Olig1 conditional knockout mice, chromatin immunoprecipitation (Olig1 binding to Dlx1/2 I12b enhancer), genetic epistasis (Dlx1/2 downstream of Olig1), cell counting\",\n      \"journal\": \"Neuron\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Strong — ChIP demonstrating direct enhancer binding, genetic epistasis established, loss-of-function phenotype quantified, multiple orthogonal methods\",\n      \"pmids\": [\"24507192\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2014,\n      \"finding\": \"TIP30 sequesters Olig1 in the cytoplasm by direct protein–protein interaction, preventing its nuclear translocation and thereby inhibiting OPC differentiation; TIP30 overexpression inhibits OPC stage progression while TIP30 knockdown enhances oligodendroglial differentiation and increases nuclear Olig1.\",\n      \"method\": \"Co-immunoprecipitation (TIP30–Olig1 interaction), TIP30 overexpression/knockdown in primary OPC cultures, subcellular localization by immunostaining, cuprizone demyelination model\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — Co-IP plus gain/loss-of-function with defined localization and differentiation phenotype, single lab\",\n      \"pmids\": [\"25530119\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Olig1 acetylation at Lys150 (human Olig1) drives nuclear-to-cytoplasmic translocation. The acetyltransferase CBP (CREB-binding protein) and deacetylases HDAC1, HDAC3, and HDAC10 regulate this modification. Acetylation decreases Olig1 chromatin association, increases interaction with ID2, and facilitates cytoplasmic retention in mature oligodendrocytes. Three functional nuclear export sequences (NES) were identified in the bHLH domain.\",\n      \"method\": \"Identification of acetylation site (Lys150) by mutagenesis, CBP/HDAC overexpression/knockdown, chromatin association assays, Co-IP (Olig1–ID2 interaction), subcellular fractionation/immunostaining in mouse and rat oligodendrocytes\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — specific residue mutagenesis, identified writer (CBP) and erasers (HDAC1/3/10), interaction partner (ID2), and functional consequence on chromatin/localization, multiple orthogonal methods in single lab\",\n      \"pmids\": [\"26631469\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2015,\n      \"finding\": \"Olig1 is required for oligodendrocyte progenitor cell commitment and differentiation in the brain corpus callosum, with hypomyelination persisting into adulthood. In the spinal cord, compensatory upregulation of Olig2 protein (not seen in brain) partially rescues the deficit, explaining the regional difference in Olig1 requirement.\",\n      \"method\": \"Olig1-null mouse analysis, Olig2 protein quantification by Western blot and immunostaining, myelination assessment by electron microscopy and immunostaining\",\n      \"journal\": \"The Journal of neuroscience\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic knockout with regional comparison, Olig2 compensatory upregulation as mechanistic explanation, multiple readouts\",\n      \"pmids\": [\"25762682\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Olig1 protein translocates from the cytoplasm to the nucleus in EAE (demyelination) rat brains, and progesterone treatment increases the proportion of cells showing nuclear Olig1 localization, correlating with enhanced remyelination.\",\n      \"method\": \"Immunostaining for Olig1 subcellular localization in EAE rat brain, electron microscopy for myelin assessment, progesterone injection paradigm\",\n      \"journal\": \"Neuroscience letters\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — single lab, correlative localization data without direct mechanistic manipulation of Olig1\",\n      \"pmids\": [\"20381586\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2010,\n      \"finding\": \"Olig1 and ID4 directly interact and form a dimer in living cells; the Olig1–ID4 complex localizes to the cytoplasm (whereas Olig1 alone is nuclear and ID4 alone is cytoplasmic), indicating that ID4 blocks nuclear transport of Olig1.\",\n      \"method\": \"Bimolecular fluorescence complementation (BiFC) in SW1116 cells, EGFP/DsRed2 fusion protein co-expression and colocalization\",\n      \"journal\": \"Molecular biology reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Weak — direct visualization of protein–protein interaction in living cells with defined localization consequence, single lab, single method\",\n      \"pmids\": [\"21132377\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"Olig1 function is required downstream of Noggin (BMP antagonism) for OPC production after neonatal stroke; in postnatal neural progenitors, Noggin governs OL versus interneuron fate through Olig1-mediated repression of Dlx1/2 transcription factors. Olig1-null neonatal mice show hypomyelination and replacement of OPCs with proliferating neuronal precursors and GABAergic interneurons in damaged white matter.\",\n      \"method\": \"Olig1-null mice subjected to neonatal stroke, postnatal neural progenitor cultures with Noggin treatment, immunostaining for lineage markers\",\n      \"journal\": \"Annals of neurology\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — genetic loss-of-function with defined pathway placement (Noggin→Olig1→Dlx1/2 repression), in vitro and in vivo, single lab\",\n      \"pmids\": [\"28253550\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2017,\n      \"finding\": \"HMGN proteins regulate OLIG1 and OLIG2 expression through chromatin dynamics: loss of HMGNs increases histone H1 chromatin binding at Olig1/2 loci, recruiting the methyltransferase EZH2 and elevating H3K27me3 (repressive mark), thereby reducing Olig1/2 expression and impeding oligodendrocyte lineage specification.\",\n      \"method\": \"HMGN knockout ESC differentiation assays, ChIP for H1/EZH2/H3K27me3 at Olig1/2 loci, gene expression analysis, mouse behavioral and histological phenotyping\",\n      \"journal\": \"Nucleic acids research\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — ChIP demonstrating epigenetic mechanism at Olig1 locus, ESC differentiation and in vivo mouse phenotype, single lab\",\n      \"pmids\": [\"27923998\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2021,\n      \"finding\": \"Quetiapine upregulates Olig1 expression and promotes nuclear-to-cytoplasmic translocation of Olig1, where cytoplasmic Olig1 (not as transcription factor) drives oligodendroglial membrane expansion and maturation. Quetiapine also reverses GPR17-mediated inhibition of oligodendroglial morphological maturation, with Olig1 identified as upstream regulator of GPR17.\",\n      \"method\": \"Primary oligodendrocyte cultures, quetiapine treatment, Olig1 subcellular localization by immunostaining, morphological quantification, GPR17 expression analysis\",\n      \"journal\": \"Glia\",\n      \"confidence\": \"Low\",\n      \"confidence_rationale\": \"Tier 3 / Weak — pharmacological manipulation without direct genetic proof of Olig1 as mediator, single lab, correlative mechanism\",\n      \"pmids\": [\"33660902\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2024,\n      \"finding\": \"Olig1 promotes axonal regeneration in spinal motor neurons; Olig1 overexpression facilitates axonal regeneration in multiple injury models while deletion has the opposite effect. Olig1 acts at least partially through transcriptional regulation of the neurite extension factor Nrsn1.\",\n      \"method\": \"Transcriptomic profiling of motor neurons with differential regenerative capacity, Olig1 overexpression/deletion in regeneration models, identification of Nrsn1 as downstream target by differential gene expression and functional validation\",\n      \"journal\": \"Cell reports\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 2 / Moderate — gain- and loss-of-function in multiple models with defined downstream target (Nrsn1), single lab\",\n      \"pmids\": [\"39002126\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Olig1 and Olig2 coordinately regulate cortical astrocyte maturation by directly binding the Bmp7 enhancer and repressing Bmp7 expression; genetic ablation of both Olig1 and Olig2 results in defective astrocyte morphology and immature gene expression, while Bmp7 overexpression in vivo replicates this phenotype.\",\n      \"method\": \"Olig1/2 double knockout mice, single-cell RNA sequencing, ChIP/CUT&Tag for Olig1/2 binding at Bmp7 enhancer, Bmp7 overexpression in vivo\",\n      \"journal\": \"Journal of genetics and genomics\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct enhancer binding demonstrated, genetic epistasis via Bmp7 overexpression phenocopy, scRNA-seq, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"40139307\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"Olig1 and Olig2 coordinately regulate Tri-IPC fate specification in cortical gliogenesis by activating OPC specification while repressing OBIN-IPC generation through direct binding to multiple conserved enhancer elements of Gsx2, suppressing its expression; Olig1/2 genetic ablation redirects progenitors from OPC to OBIN-IPC fate with Gsx2 upregulation.\",\n      \"method\": \"Olig1/2 double knockout mouse genetics, CUT&Tag-seq for Olig1/2 binding at Gsx2 enhancers, single-cell transcriptomics, in vivo mutagenesis\",\n      \"journal\": \"Nature communications\",\n      \"confidence\": \"High\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — genome-wide binding (CUT&Tag) at specific enhancers, genetic loss-of-function with defined cell fate switch, multi-omics, single lab with multiple orthogonal methods\",\n      \"pmids\": [\"41193423\"],\n      \"is_preprint\": false\n    },\n    {\n      \"year\": 2025,\n      \"finding\": \"OLIG1 and OLIG2 drive GBM tumor cell proliferation by directly binding to promoter regions of cyclins (Cdk4, Ccne2, Ccnd3, Ccnd1), marked by H3K4me3 (active histone mark), leading to transcriptional activation; Olig1/2 knockout reduces proliferation but does not suppress tumor initiation or migration.\",\n      \"method\": \"CRISPR/Cas9 Olig1/2 knockout in GBM mouse model, CUT&Tag-seq for Olig1/2 binding at cyclin promoters, H3K4me3 ChIP, tumor proliferation assays\",\n      \"journal\": \"Genes\",\n      \"confidence\": \"Medium\",\n      \"confidence_rationale\": \"Tier 1–2 / Moderate — direct promoter binding by CUT&Tag with histone mark validation, genetic knockout with defined proliferation phenotype, single lab\",\n      \"pmids\": [\"40428395\"],\n      \"is_preprint\": false\n    }\n  ],\n  \"current_model\": \"OLIG1 is a bHLH transcription factor that promotes oligodendrocyte differentiation and myelinogenesis (primarily in brain) by activating myelin gene transcription (Mbp, Plp1, Mag) in complex with SOX10, repressing interneuron production via direct suppression of Dlx1/2 enhancers, and regulating astrocyte maturation through Bmp7 enhancer repression; its activity is controlled by phosphorylation at Ser138 and acetylation at Lys150 (regulated by CBP/HDAC1/3/10), which govern nuclear-cytoplasmic shuttling—nuclear Olig1 drives myelin gene transcription while phosphorylated cytoplasmic Olig1 promotes membrane expansion—and its interaction partners include SOX10, Smad2/3 (as a TGF-β co-factor regulated by Pin1), ID2, ID4 (which sequesters Olig1 in the cytoplasm), and TIP30 (which blocks nuclear translocation).\"\n}\n```","stage2_raw":"{\n  \"mechanistic_narrative\": \"OLIG1 is a basic helix-loop-helix transcription factor that operates at the crossroads of neuronal versus glial fate decisions and drives the oligodendrocyte differentiation and myelination program in the CNS [#0, #1]. In progenitor specification, OLIG1 (with OLIG2) directs cells toward the oligodendrocyte lineage and away from interneuron fates: it directly binds and represses the Dlx1/2 I12b intergenic enhancer to restrain cortical GABAergic interneuron production [#7], represses the Gsx2 enhancers to bias Tri-IPC progenitors toward OPC rather than OBIN-IPC fate [#18], and is required downstream of BMP antagonism (Noggin) for OPC production after injury [#13]. During myelinogenesis it activates myelin-specific genes (Mbp, Plp1, Mag) and suppresses the astrocyte gene Gfap, with brain-specific requirement because spinal cord deficits are buffered by compensatory OLIG2 upregulation [#1, #10]; mechanistically, OLIG1 partners with SOX10 to transactivate the mbp promoter [#2]. OLIG1 activity is governed by regulated nuclear-cytoplasmic shuttling: phosphorylation at Ser138 and acetylation at Lys150 (written by CBP and erased by HDAC1/3/10) drive nuclear export, where cytoplasmic OLIG1 promotes oligodendroglial membrane expansion while nuclear OLIG1 sustains myelin gene transcription [#5, #9]. Cytoplasmic sequestration is enforced by direct binding partners including ID2, ID4, and TIP30, which block OLIG1 nuclear translocation [#9, #12, #8]. Beyond oligodendrocytes, OLIG1 acts as a Smad2/3 cofactor regulated by Pin1 to promote TGF-\\u03b2-induced cell motility [#6] and, with OLIG2, represses a Bmp7 enhancer to control astrocyte maturation [#17].\",\n  \"teleology\": [\n    {\n      \"year\": 2002,\n      \"claim\": \"Established the foundational role of Olig genes in coupling neuronal and glial subtype specification, answering whether a single factor class governs both motoneuron and oligodendrocyte production.\",\n      \"evidence\": \"Olig1/2 double-knockout mice with lineage tracing in the spinal cord pMN domain\",\n      \"pmids\": [\"11955447\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not separate OLIG1- from OLIG2-specific contributions\", \"Direct transcriptional targets not identified\"]\n    },\n    {\n      \"year\": 2005,\n      \"claim\": \"Defined OLIG1 as a dedicated driver of brain myelinogenesis, distinguishing OPC formation from the subsequent differentiation/myelin-wrapping step it controls.\",\n      \"evidence\": \"Olig1-null mice with myelin gene expression analysis and electron microscopy\",\n      \"pmids\": [\"15703389\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Direct DNA targets in myelin gene loci not mapped\", \"Basis of brain vs spinal cord specificity unexplained at this stage\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Identified a direct molecular mechanism for myelin gene activation by showing OLIG1 forms a transactivating complex with SOX10 on the mbp promoter.\",\n      \"evidence\": \"Co-IP and promoter-reporter assays in zebrafish and mouse\",\n      \"pmids\": [\"18160645\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Cross-species divergence in OLIG2-SOX10 binding leaves complex stoichiometry unresolved\", \"Full set of co-regulated promoters not defined\"]\n    },\n    {\n      \"year\": 2007,\n      \"claim\": \"Placed Olig1/2 downstream of BMP signaling in the OPC-versus-astrocyte fate decision, clarifying how extracellular cues gate the oligodendrocyte program.\",\n      \"evidence\": \"Adult OPC culture with BMP treatment and olig1/olig2 overexpression rescue\",\n      \"pmids\": [\"17872503\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Requires both Olig1 and Olig2 for full rescue, so Olig1-specific sufficiency unclear\", \"Single lab\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Connected Olig1/2 gene dosage to interneuron number, demonstrating that triplication causes excitatory/inhibitory imbalance reversible by dosage normalization.\",\n      \"evidence\": \"Genetic dosage normalization in Ts65Dn Down syndrome mice with cell counting and electrophysiology\",\n      \"pmids\": [\"20639873\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Did not resolve direct transcriptional mechanism of interneuron suppression\", \"Olig1 vs Olig2 individual dosage contribution not separated\"]\n    },\n    {\n      \"year\": 2010,\n      \"claim\": \"Provided first evidence that OLIG1 subcellular localization is regulated and correlates with remyelination, and that ID4 directly blocks its nuclear transport.\",\n      \"evidence\": \"Olig1 immunolocalization in EAE rat brain with progesterone treatment; BiFC of Olig1-ID4 dimer in cells\",\n      \"pmids\": [\"20381586\", \"21132377\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"EAE/progesterone data are correlative without direct Olig1 manipulation\", \"BiFC is single-method without functional differentiation readout\"]\n    },\n    {\n      \"year\": 2012,\n      \"claim\": \"Identified Ser138 phosphorylation as a switch controlling OLIG1 nuclear-cytoplasmic distribution and uncoupling myelin gene transcription from membrane expansion.\",\n      \"evidence\": \"Phosphosite identification and S138A/S138D mutagenesis with rescue in Olig1-null OPCs and morphology quantification\",\n      \"pmids\": [\"22639060\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Kinase responsible for Ser138 phosphorylation not identified\", \"Cytoplasmic effector mechanism for membrane expansion undefined\"]\n    },\n    {\n      \"year\": 2013,\n      \"claim\": \"Revealed a non-glial role for OLIG1 as a Smad2/3 cofactor in TGF-\\u03b2-driven cell motility, regulated by Pin1.\",\n      \"evidence\": \"Reciprocal Co-IP mapping interaction to the Smad3 L3 loop, siRNA knockdown, migration/wound-healing assays, peptide inhibition\",\n      \"pmids\": [\"23720758\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Target genes mediating motility not identified\", \"Relevance to oligodendrocyte biology not established\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Demonstrated that OLIG1 directly represses the Dlx1/2 enhancer to limit GABAergic interneuron production, providing the molecular basis for the neuron/glia fate switch.\",\n      \"evidence\": \"Olig1 conditional knockout, ChIP at the Dlx1/2 I12b enhancer, genetic epistasis, cell counting\",\n      \"pmids\": [\"24507192\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Co-repressor complex at the enhancer not characterized\", \"Interplay with OLIG2 at this locus not resolved\"]\n    },\n    {\n      \"year\": 2014,\n      \"claim\": \"Identified TIP30 as a direct cytoplasmic sequestration factor controlling the timing of OLIG1 nuclear entry and OPC differentiation.\",\n      \"evidence\": \"Co-IP, TIP30 gain/loss-of-function in primary OPCs, localization imaging, cuprizone demyelination model\",\n      \"pmids\": [\"25530119\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Reciprocal Co-IP not reported\", \"Relationship between TIP30 and the phospho/acetyl shuttling code unknown\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Defined an acetylation-based export code (Lys150, CBP writer, HDAC1/3/10 erasers, NES signals) that reduces chromatin association and routes OLIG1 to the cytoplasm via ID2 binding in mature oligodendrocytes.\",\n      \"evidence\": \"Lys150 mutagenesis, CBP/HDAC manipulation, chromatin association assays, Olig1-ID2 Co-IP, fractionation in mouse/rat oligodendrocytes\",\n      \"pmids\": [\"26631469\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Crosstalk between Ser138 phosphorylation and Lys150 acetylation not resolved\", \"In vivo significance of NES mutants not tested\"]\n    },\n    {\n      \"year\": 2015,\n      \"claim\": \"Explained the brain-specific requirement for OLIG1 by showing compensatory OLIG2 protein upregulation rescues spinal but not brain myelination deficits.\",\n      \"evidence\": \"Olig1-null mouse analysis with OLIG2 quantification, electron microscopy, immunostaining in corpus callosum\",\n      \"pmids\": [\"25762682\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"Mechanism restricting OLIG2 compensation to spinal cord unknown\", \"Long-term functional myelin consequences not fully characterized\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Integrated OLIG1 into the BMP-antagonism injury response, positioning it downstream of Noggin to govern OL-versus-interneuron fate via Dlx1/2 repression after stroke.\",\n      \"evidence\": \"Olig1-null neonatal stroke model and Noggin-treated postnatal progenitor cultures with lineage marker staining\",\n      \"pmids\": [\"28253550\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct link between Noggin signaling and Olig1 regulation not mapped molecularly\", \"Single lab\"]\n    },\n    {\n      \"year\": 2017,\n      \"claim\": \"Showed that Olig1/2 expression itself is set by chromatin state, with HMGN proteins preventing EZH2/H3K27me3-mediated silencing of the loci.\",\n      \"evidence\": \"HMGN-knockout ESC differentiation, ChIP for H1/EZH2/H3K27me3 at Olig1/2 loci, mouse phenotyping\",\n      \"pmids\": [\"27923998\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Olig1- vs Olig2-locus-specific effects not separated\", \"Upstream signals controlling HMGN occupancy unknown\"]\n    },\n    {\n      \"year\": 2021,\n      \"claim\": \"Linked pharmacological induction of cytoplasmic OLIG1 to oligodendroglial membrane maturation and GPR17 regulation, supporting the cytoplasmic non-transcriptional function.\",\n      \"evidence\": \"Quetiapine treatment of primary oligodendrocytes with localization imaging and GPR17 analysis\",\n      \"pmids\": [\"33660902\"],\n      \"confidence\": \"Low\",\n      \"gaps\": [\"No direct genetic proof that Olig1 mediates quetiapine effect\", \"Mechanism of GPR17 regulation by Olig1 not defined\"]\n    },\n    {\n      \"year\": 2024,\n      \"claim\": \"Extended OLIG1 function to neuronal axon biology, showing it promotes spinal motor neuron axonal regeneration partly via transcriptional control of Nrsn1.\",\n      \"evidence\": \"Transcriptomics of motor neurons, Olig1 overexpression/deletion in regeneration models, Nrsn1 functional validation\",\n      \"pmids\": [\"39002126\"],\n      \"confidence\": \"Medium\",\n      \"gaps\": [\"Direct Olig1 binding at Nrsn1 not demonstrated\", \"Full regenerative target set unknown\"]\n    },\n    {\n      \"year\": 2025,\n      \"claim\": \"Mapped genome-wide enhancer/promoter binding establishing OLIG1/2 as direct repressors (Bmp7, Gsx2) in astrocyte maturation and gliogenic fate and direct activators (cyclins) driving GBM proliferation.\",\n      \"evidence\": \"Olig1/2 double-knockout mice, CUT&Tag-seq, scRNA-seq, H3K4me3 ChIP, in vivo overexpression phenocopy and CRISPR knockout in GBM\",\n      \"pmids\": [\"40139307\", \"41193423\", \"40428395\"],\n      \"confidence\": \"High\",\n      \"gaps\": [\"OLIG1-specific versus OLIG2-specific binding contributions not separated\", \"Switch between repressive and activating modes at different loci not mechanistically explained\"]\n    },\n    {\n      \"year\": null,\n      \"claim\": \"How the phosphorylation (Ser138) and acetylation (Lys150) shuttling codes are integrated with the sequestration partners (ID2/ID4/TIP30) and upstream signals to time the nuclear-to-cytoplasmic transition during differentiation remains unresolved.\",\n      \"evidence\": \"\",\n      \"pmids\": [],\n      \"confidence\": \"High\",\n      \"gaps\": [\"No unified model linking PTM code to partner binding\", \"Upstream kinase/signaling inputs not identified\", \"In vivo significance of cytoplasmic OLIG1 function not genetically dissected\"]\n    }\n  ],\n  \"mechanism_profile\": {\n    \"molecular_activity\": [\n      {\"term_id\": \"GO:0140110\", \"supporting_discovery_ids\": [1, 2, 7, 17, 18, 19]},\n      {\"term_id\": \"GO:0003677\", \"supporting_discovery_ids\": [7, 17, 18, 19]},\n      {\"term_id\": \"GO:0060089\", \"supporting_discovery_ids\": [6]}\n    ],\n    \"localization\": [\n      {\"term_id\": \"GO:0005634\", \"supporting_discovery_ids\": [5, 8, 9, 12]},\n      {\"term_id\": \"GO:0005829\", \"supporting_discovery_ids\": [5, 8, 9, 12]}\n    ],\n    \"pathway\": [\n      {\"term_id\": \"R-HSA-1266738\", \"supporting_discovery_ids\": [0, 1, 7, 17, 18]},\n      {\"term_id\": \"R-HSA-74160\", \"supporting_discovery_ids\": [2, 7, 17, 18, 19]},\n      {\"term_id\": \"R-HSA-162582\", \"supporting_discovery_ids\": [6, 3, 13]}\n    ],\n    \"complexes\": [],\n    \"partners\": [\"SOX10\", \"SMAD2\", \"SMAD3\", \"ID2\", \"ID4\", \"TIP30\", \"OLIG2\", \"PIN1\"],\n    \"other_free_text\": []\n  }\n}","audit_flag":null,"evaluation":{"pairwise":"win","faith_supported":6,"faith_total":6,"faith_pct":100.0}}